secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K/A
Filed at:   2026-09-24T21:41:35+00:00
Accession:  0001801170-26-000232
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 9.01, 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Clover Health adds ex-Sen. Torricelli and Johns Hopkins' Dr. Brian Miller to board, filling two vacancies
--------------------------------------------------------------------------------

- Board appointed Sen. Robert Torricelli (Class I) and Dr. Brian J. Miller (Class III) effective September 22, 2026, filling two previously disclosed vacancies; board now has nine directors.
- Torricelli, a New Jersey U.S. Senator 1997-2003 and House member 1983-1997, joins the Audit Committee; he has been a director of Clover's insurance subsidiaries since 2022.
- Miller is a Johns Hopkins Hospital hospitalist and Johns Hopkins associate professor, a MedPAC commissioner since May 2023, and vice chairman of the North Carolina State Health Plan board.
- Each receives a pro-rated 2026 retainer plus an RSU award valued at $200,000, pro-rated for days served from appointment through December 31, 2026, under Clover's director compensation policy.
- CEO Andrew Toy and Executive Chairperson Vivek Garipalli said the additions deepen board expertise in Medicare Advantage, clinical practice and healthcare policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000232/0001801170-26-000232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000232/clov-20260922.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer